Wenhua Xie

USPTO Granted Patents = 13 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 50(Granted Patents)

Location History:

Westland, MI (US) (2003 - 2005)
Brea, CA (US) (2020)
Novi, MI (US) (2007 - 2023)

Company Filing History:

Beckman Coulter, Inc.

Years Active: 2003-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49466 - Solution phase homogeneous assays (2023-03-20),

2. 10703971 - Chemiluminescent substrates (2020-07-07),

3. 10036708 - Solution phase homogeneous assays (2018-07-31),

4. 9029092 - Solution phase homogeneous assays (2015-05-12),

5. 8389298 - Methods using novel chemiluminescent labels (2013-03-05),

6. 8106203 - Assay methods using chemiluminescent detection of peroxidase (2012-01-31),

7. 7682839 - Methods using novel chemiluminescent labels (2010-03-23),

8. 7560556 - Assay methods using chemiluminescent detection of peroxidase (2009-07-14),

9. 7247726 - Compounds for generating chemiluminescence with a peroxidase (2007-07-24),

10. 6872828 - Compounds for generating chemiluminescence with a peroxidase (2005-03-29),

11. 6858733 - Compounds for generating chemiluminescence with a peroxidase (2005-02-22),

12. 6846923 - Oxime-linked polysaccharides and methods of preparing the same (2005-01-25),

13. 6528644 - Acetoacetylated saccharides and process of making the same (2003-03-04),

Title: **Innovator Spotlight: Wenhua Xie**

Introduction

Wenhua Xie, an accomplished inventor based in Novi, MI, has made significant contributions to the field of assay methods and chemiluminescence. With a remarkable portfolio of 13 patents, Xie's innovations have greatly enhanced the efficiency and effectiveness of diagnostic testing.

Latest Patents

Among his latest patents is a groundbreaking method known as "Solution phase homogeneous assays." This innovation outlines techniques, reagents, kits, and systems designed to determine an analyte in a sample suspected of containing it. The method allows for all reagents to be soluble in an aqueous solution. Xie’s approach involves treating the sample to ensure that if the analyte is present, an activator interacts with a chemiluminescent compound, leading to light production. Additionally, an agent is used to reduce any signals not related to the analyte, culminating in precise and reliable results. Another notable patent involves "Chemiluminescent substrates," which presents alkaline phosphatase chemiluminescent substrate formulations that boast rapid incubation periods and enhanced stability for immunoassays.

Career Highlights

Throughout his career, Wenhua Xie has worked with leading companies in the scientific community, including Lumigen, Inc. and Beckman Coulter, Inc. His work in these organizations has played a crucial role in advancing diagnostic methodologies and assay technologies.

Collaborations

Wenhua Xie has collaborated with several prominent professionals in his field, including Renuka De Silva and Hashem Akhavan-Tafti. Their combined expertise has contributed to the successful development of innovative solutions in diagnostics and assay techniques.

Conclusion

Wenhua Xie continues to lead the way in innovations within the diagnostic sector, with his patents reflecting a commitment to improving medical testing methodologies. His work not only highlights his ingenuity as an inventor but also underlines the importance of collaboration in advancing technology for the benefit of healthcare.

This text is generated by artificial intelligence and may not be accurate.